Is This Kidney Disease?
Yes, with an eGFR of 56 mL/min/1.73 m², this patient has Stage 3a chronic kidney disease (CKD), regardless of the normal creatinine and BUN values. 1, 2
Understanding the Diagnosis
The key principle here is that eGFR below 60 mL/min/1.73 m² alone is sufficient to diagnose CKD Stage 3 or higher—no additional markers of kidney damage are required. 1, 3 This represents loss of approximately half or more of normal adult kidney function. 1, 2
Why Normal Creatinine Doesn't Rule Out CKD
- Your creatinine of 1.12 mg/dL appears "normal" by laboratory reference ranges, but serum creatinine alone is an unreliable indicator of kidney function because it doesn't account for age, sex, muscle mass, or body size. 1
- The eGFR calculation adjusts creatinine for these factors, revealing the true functional status of the kidneys. 1
- Many patients maintain seemingly normal creatinine levels despite significantly declining kidney function—this is a well-recognized clinical pitfall. 1, 4
CKD Stage 3a Classification
- Stage 3a CKD is defined as eGFR 45-59 mL/min/1.73 m², which your value of 56 falls within. 1, 2
- At this stage, the prevalence of CKD complications increases substantially. 1, 2
- Stage 3 CKD can be diagnosed based on reduced eGFR alone without requiring additional evidence of kidney damage like proteinuria. 3
Critical Next Steps Before Confirming Diagnosis
Establish Chronicity (Essential)
CKD requires proof that the abnormality has persisted for at least 3 months. 3 A single abnormal eGFR should never be assumed to represent chronic disease, as it could result from acute kidney injury. 3
You must:
- Review any past eGFR or creatinine measurements from the last 3+ months 3
- If no prior values exist, repeat the eGFR measurement in 3 months to confirm persistence 3
- Once CKD is legitimately established with documented chronicity, the diagnosis persists even if kidney function subsequently improves 3
Measure Urine Albumin-to-Creatinine Ratio (UACR)
Albuminuria assessment is mandatory to complete risk stratification, as this determines true CKD risk category independent of eGFR. 1, 3
- An albumin-to-creatinine ratio ≥30 mg/g in a spot urine sample indicates kidney damage. 1
- The presence and severity of albuminuria dramatically affects prognosis and treatment intensity. 1, 3
- Patients with Stage 3a CKD and no albuminuria have substantially better outcomes than those with albuminuria. 1
Consider Confirmatory Testing with Cystatin C
For patients with eGFR 45-59 mL/min/1.73 m² who do not have other markers of kidney damage (like albuminuria), measuring cystatin C can confirm the CKD diagnosis. 1
- Approximately two-thirds of persons with creatinine-based eGFR <60 will have cystatin C-based eGFR <60, confirming CKD. 1
- Those with confirmed CKD by both markers have markedly elevated risks for death, cardiovascular disease, and end-stage renal disease. 1
Clinical Implications
This Patient Requires:
- Annual monitoring at minimum: serum creatinine, eGFR calculation, UACR, and blood pressure at every visit 1, 3
- Medication review for nephrotoxic agents and dose adjustments based on eGFR 1, 3
- Blood pressure control with target <130/80 mmHg 3
- Cardiovascular risk reduction, as decreased eGFR is an independent predictor of cardiovascular disease and death, even in elderly patients 1, 2
Age Considerations
The definition of CKD is the same regardless of age. 1, 2 Although GFR naturally declines with aging, decreased eGFR in elderly patients remains an independent predictor of adverse outcomes and requires the same diagnostic approach and medication adjustments. 1
Common Pitfalls to Avoid
- Don't rely on creatinine or BUN alone—they grossly overestimate kidney function in many patients 1, 4
- Don't dismiss reduced eGFR as "normal aging"—it carries real clinical consequences 1, 2
- Don't diagnose CKD from a single measurement—chronicity must be established 3
- Don't forget to check for albuminuria—it's essential for complete risk assessment 1, 3